Key result
In the United States, the prevalence of undiagnosed diabetes varies by race and ethnicity, with higher rates among Hispanic (7.5%), Asian (7.5%), and Black (5.2%) Americans compared to White Americans (3.9%).
Highlights the racial and ethnic disparities in diabetes prevalence and complications, supporting the need for race/ethnicity-specific screening thresholds.
EditorialsJune 2022Diabetes Screening: Different Thresholds for Different Racial/Ethnic GroupsQuyen Ngo-Metzger, MD, MPHQuyen Ngo-Metzger, MD, MPHDepartment of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M22-1235 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In the United States, diabetes prevalence varies in different racial/ethnic groups. Black, Hispanic, and Asian Americans have higher age- and sex-adjusted diabetes rates than non-Hispanic White Americans (1). Further, NHANES (National Health and Nutrition Examination Survey) found that the prevalence of undiagnosed diabetes also varies, with 3.9% of non-Hispanic White Americans, 5.2% of non-Hispanic Black Americans, 7.5% of Hispanic Americans, and 7.5% of non-Hispanic Asian Americans having undiagnosed diabetes (1). Racial/ethnic disparities also occur in diabetes complications, including higher rates of retinopathy, chronic kidney disease, lower-extremity amputation, and cardiovascular and cerebral vascular disease among Black, Hispanic, and Asian persons than ...References1. Cheng YJ, Kanaya AM, Araneta MRG, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011-2016. JAMA. 2019;322:2389-2398. [PMID: 31860047] doi:10.1001/jama.2019.19365 CrossrefMedlineGoogle Scholar2. Haw JS, Shah M, Turbow S, et al. Diabetes complications in racial and ethnic minority populations in the USA. Curr Diab Rep. 2021;21:2. [PMID: 33420878] doi:10.1007/s11892-020-01369-x CrossrefMedlineGoogle Scholar3. U.S. Preventive Services Task Force. Draft recommendation: hormone therapy for the prevention of chronic conditions. 2017. Accessed at https://uspreventiveservicestaskforce.org/uspstf on 18 April 2022. Google Scholar4. Davidson KW, Barry MJ, Mangione CM, et al; US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326:736-743. [PMID: 34427594] doi:10.1001/jama.2021.12531 CrossrefMedlineGoogle Scholar5. Aggarwal R, Bibbins-Domingo K, Yeh RW, et al. Diabetes screening by race and ethnicity in the United States: equivalent body mass index and age thresholds. Ann Intern Med. 2022;175:765-73. doi:10.7326/M20-8079 LinkGoogle Scholar6. Doubeni CA, Simon M, Krist AH. Addressing systemic racism through clinical preventive service recommendations from the US Preventive Services Task Force. JAMA. 2021;325:627-628. [PMID: 33492333] doi:10.1001/jama.2020.26188 CrossrefMedlineGoogle Scholar7. Virtanen M, Ferrie JE, Tabak AG, et al. Psychological distress and incidence of type 2 diabetes in high-risk and low-risk populations: the Whitehall II Cohort Study. Diabetes Care. 2014;37:2091-7. [PMID: 24784831] doi:10.2337/dc13-2725 CrossrefMedlineGoogle Scholar8. Hackett RA, Kivimäki M, Kumari M, et al. Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the Whitehall II Cohort Study. J Clin Endocrinol Metab. 2016;101:619-25. [PMID: 26647151] doi:10.1210/jc.2015-2853 CrossrefMedlineGoogle Scholar9. Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017;1391:20-34. [PMID: 27750377] doi:10.1111/nyas.13217 CrossrefMedlineGoogle Scholar10. Canedo JR, Miller ST, Schlundt D, et al. Racial/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status. J Racial Ethn Health Disparities. 2018;5:7-14. [PMID: 28078660] doi:10.1007/s40615-016-0335-8 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Quyen Ngo-Metzger, MD, MPHAffiliations: Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California Disclosures: The author has reported no disclosures of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-1235.Corresponding Author: Quyen Ngo-Metzger, MD, MPH, Kaiser Permanente Bernard J. Tyson School of Medicine, 100 South Los Robles, Suite 301, Pasadena, CA 91101; e-mail, Quyen.N.[email protected].org.This article was published at Annals.org on 10 May 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDiabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds Rahul Aggarwal , Kirsten Bibbins-Domingo , Robert W. Yeh , Yang Song , Nicholas Chiu , Rishi K. Wadhera , Changyu Shen , and Dhruv S. Kazi Metrics June 2022Volume 175, Issue 6Page: 895-896KeywordsAfrican American peopleAsian peopleBody mass indexDiabetes mellitusHealth screeningHispanic peopleRacial and ethnic issues ePublished: 10 May 2022 Issue Published: June 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Quyen Ngo‐Metzger (2022) conducted an editorial in Diabetes. In the United States, the prevalence of undiagnosed diabetes varies by race and ethnicity, with higher rates among Hispanic (7.5%), Asian (7.5%), and Black (5.2%) Americans compared to White Americans (3.9%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: